Keytone Ventures
News,Biotech / MedTech,Singapore,Investments
MiRXES secures $77M Series C funding to accelerate multi-cancer early detection pipeline
Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.
July 8, 2021
Asian developers lean on AI agents, still 86% needs human review: Agoda
September 25, 2026
Asian developers lean on AI agents, still 86% needs human review: Agoda
September 25, 2026




